Moderna and Merck announced their mRNA cancer vaccine combined with immunotherapy Keytruda reduced melanoma death or recurrence risk by 42 per cent in a Phase 3 trial. The personalised vaccine, intismeran autogene, targets tumour-specific mutations. The companies plan to file for US approval and lau
A practical guide for Hong Kong small businesses using IMG.now to create product visuals. Covers prompt design, editing, copyright, alt text, and a human-review checklist before commercial publication.
